Author： Bickel Markus
Publisher： Govi-Verlag
ISSN： 2195-2175
Source： PHARMAKON, Vol.2, Iss.5, 2014-09, pp. : 344-347
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Tackling resistance in HIV infection
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :
Access to resources
Recommend
Cryptococcal disease and HIV infection
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. :
Treatment of HIV infection with raltegravir
By Chirch Lisa M Morrison Sidonie Steigbigel Roy T
Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 7, 2009-05 ,pp. :
Antifungal use in HIV infection
By Mylonakis Eleftherios Marty Francisco
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 2, 2002-02 ,pp. :
The Metabolic Syndrome and HIV Infection
Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-09 ,pp. :